ImmuCell Corporation Other Noncash Income Tax Expense
ImmuCell Corporation (ICCC) reported Other Noncash Income Tax Expense of $563.25 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeTaxExpense · last filed 2026-08-13
- ImmuCell Corporation other noncash income tax expense for the quarter ending 2018-09-30 was $563.25K.
- ImmuCell Corporation other noncash income tax expense for the quarter ending 2018-06-30 was $563.25K.
- ImmuCell Corporation other noncash income tax expense for fiscal 2018 was $563.25K.
| Period end | Other Noncash Income Tax Expense 3 month | Other Noncash Income Tax Expense 6 month | Other Noncash Income Tax Expense 9 month | Other Noncash Income Tax Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $563.25K 10-Q · filed 2023-11-13 | |||
| 2018-12-31 | $563.25K 10-K · filed 2025-03-28 | |||
| 2018-09-30 | $563.25K 10-Q · filed 2026-08-13 | $1.13M derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2018-06-30 | $563.25K 10-Q · filed 2025-08-14 | $563.25K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |